TRISTAN HASBARGEN: Open Payments
NPI 1861746778 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$104,887 in 224 payments from 20 companies in 2025. Trend: 2023 $67,254 · 2024 $65,025 · 2025 $104,887
Speaker / faculty: $72,641Consulting: $18,392Travel & lodging: $9,277Food & beverage: $4,369Education: $207
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 89 | $55,055 |
| Eli Lilly and Company | 33 | $17,907 |
| UCB, Inc. | 38 | $17,143 |
| GENZYME CORPORATION | 13 | $7,921 |
| Regeneron Pharmaceuticals, Inc. | 4 | $1,782 |
| Janssen Biotech, Inc. | 8 | $1,658 |
| LEO Pharma Inc. | 4 | $1,317 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $1,204 |
| Novartis Pharmaceuticals Corporation | 5 | $203 |
| ABBVIE INC. | 3 | $176 |
Products named: EBGLYSS, Bimzelx, DUPIXENT, TALTZ, TREMFYA, Odomzo, RINVOQ, COSENTYX.
Industry payments across FL — which companies pay providers there.
